IB Acquisition Corp. (IBACR) stock
IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC
$0.10−0.00 (-3.50%)
Close on Oct 30, 2026Market cap $54.39MP/E –Yield –
IB Acquisition operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
IB Acquisition's operating income for the twelve months ending Jun 30, 2026 was -$1.79M. For fiscal 2025 it was -$748.91K.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$748.91K | – |
| FY2024 | Sep 30, 2024 | -$523.97K | – |
| FY2023 | Sep 30, 2023 | -$6.84K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Jun 30, 2026 | -$624.43K | – |
| Q2 FY2026 | Mar 31, 2026 | -$748.18K | – |
| Q1 FY2026 | Dec 31, 2025 | -$180.00K | – |
| Q4 FY2025 | Sep 30, 2025 | -$236.77K | – |
| Q3 FY2025 | Jun 30, 2025 | -$172.21K | – |
| Q2 FY2025 | Mar 31, 2025 | -$163.49K | – |
| Q1 FY2025 | Dec 31, 2024 | -$176.44K | – |
| Q4 FY2024 | Sep 30, 2024 | -$165.46K | – |
| Q3 FY2024 | Jun 30, 2024 | -$76.38K | – |
| Q2 FY2024 | Mar 31, 2024 | -$194.65K | – |
| Q1 FY2024 | Dec 31, 2023 | -$87.49K | – |
| Q4 FY2023 | Sep 30, 2023 | -$6.70K | – |
| Q3 FY2023 | Jun 30, 2023 | -$48 | – |
| Q2 FY2023 | Mar 31, 2023 | -$48 | – |